ATOZET2
Le remboursement s'applique aux situations suivantes:
 - patients à haut risque, selon la catégorie de …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
10.845 MG | Substance | WIZUS |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FTODK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
FTAB
|
2.88 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
2.36 MG | Substance | HBESI |
4051 Basel